DE69123871D1 - Anti-Oncostatin-M monoklonale Antikörper - Google Patents

Anti-Oncostatin-M monoklonale Antikörper

Info

Publication number
DE69123871D1
DE69123871D1 DE69123871T DE69123871T DE69123871D1 DE 69123871 D1 DE69123871 D1 DE 69123871D1 DE 69123871 T DE69123871 T DE 69123871T DE 69123871 T DE69123871 T DE 69123871T DE 69123871 D1 DE69123871 D1 DE 69123871D1
Authority
DE
Germany
Prior art keywords
oncostatin
monoclonal antibodies
inhibiting
antibodies
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69123871T
Other languages
English (en)
Other versions
DE69123871T2 (de
Inventor
Susan F Radka
Peter S Linsley
Mohammed Shoyab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE69123871D1 publication Critical patent/DE69123871D1/de
Application granted granted Critical
Publication of DE69123871T2 publication Critical patent/DE69123871T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69123871T 1990-03-29 1991-03-26 Anti-Oncostatin-M monoklonale Antikörper Expired - Lifetime DE69123871T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50182490A 1990-03-29 1990-03-29
US66419191A 1991-03-04 1991-03-04

Publications (2)

Publication Number Publication Date
DE69123871D1 true DE69123871D1 (de) 1997-02-13
DE69123871T2 DE69123871T2 (de) 1997-08-14

Family

ID=27053942

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69123871T Expired - Lifetime DE69123871T2 (de) 1990-03-29 1991-03-26 Anti-Oncostatin-M monoklonale Antikörper

Country Status (17)

Country Link
EP (1) EP0451612B1 (de)
JP (1) JPH05244980A (de)
KR (1) KR910016345A (de)
AT (1) ATE147106T1 (de)
AU (1) AU649658B2 (de)
CA (1) CA2039231A1 (de)
DE (1) DE69123871T2 (de)
DK (1) DK0451612T3 (de)
ES (1) ES2097160T3 (de)
GR (1) GR3022222T3 (de)
HU (1) HUT62039A (de)
IE (1) IE911078A1 (de)
IL (1) IL97623A (de)
NO (2) NO303226B1 (de)
NZ (1) NZ237533A (de)
OA (1) OA09745A (de)
PT (1) PT97179B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
AU1615701A (en) * 1999-11-16 2001-05-30 General Hospital Corporation, The Compositions and methods for regulating tumor-associated antigen expression
EP2627356B1 (de) 2010-10-13 2019-05-22 Janssen Biotech, Inc. Menschliche oncostatin-m-antikörper und verwendungsverfahren dafür
WO2016046738A1 (en) 2014-09-24 2016-03-31 Università Degli Studi Di Padova Composition to induce bone marrow stem cell mobilization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
ATE147106T1 (de) 1997-01-15
PT97179B (pt) 1998-07-31
OA09745A (en) 1993-11-30
JPH05244980A (ja) 1993-09-24
IL97623A (en) 1996-01-19
NO911127D0 (no) 1991-03-21
DK0451612T3 (da) 1997-06-16
NO303226B1 (no) 1998-06-15
EP0451612A1 (de) 1991-10-16
NO911127L (no) 1991-09-30
NO974793L (no) 1991-09-30
IE911078A1 (en) 1991-10-09
KR910016345A (ko) 1991-11-05
EP0451612B1 (de) 1997-01-02
CA2039231A1 (en) 1991-09-30
GR3022222T3 (en) 1997-04-30
AU649658B2 (en) 1994-06-02
AU7390891A (en) 1991-11-07
NO974793D0 (no) 1997-10-17
HUT62039A (en) 1993-03-29
PT97179A (pt) 1991-11-29
NZ237533A (en) 1992-12-23
HU911006D0 (en) 1991-10-28
DE69123871T2 (de) 1997-08-14
NO305867B1 (no) 1999-08-09
ES2097160T3 (es) 1997-04-01

Similar Documents

Publication Publication Date Title
DE69232137T2 (de) Multivalente antigen-bindende proteine
DE69016401D1 (de) Optischer Sensor zur Bestimmung der Zusammensetzung von Brennstoff.
DE69022891D1 (de) Gerät zur Kompensierung von Videosignalen.
DE68917346D1 (de) Optischer Sensor zur Richtungsbestimmung eintreffender Strahlung.
DE69638269D1 (de) Hochaffine humane antikörper gegen tumorantigene
HUP9904052A3 (en) Monoclonal antibodies againts the extracellular domain of human vegf-receptor protein (kdr)
DE69204318D1 (de) Vorrichtung zur Bestimmung der Dielektrizitätskonstante von Kraftstoff.
DE68918217D1 (de) Familie von modifizierten Antikörpern mit hoher Affinität zur Behandlung von Krebs.
NO910209L (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18-antistoffer.
DE69630078D1 (de) Gerät zur Kompensation der Rasterpositionsfehler von Ausgabe-Scannern
DE69101474D1 (de) Stabilisiertes Emulsionssystem.
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
DE69232875D1 (de) MHC-Konjugate zur Verbesserung der Autoimmunität.
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ES2097160T3 (es) Anticuerpos monoclonales anti-oncostantina m.
FR2679523B1 (fr) Dispositif pour la paletisation de fauteuils repliables.
ZA92586B (en) Composition of antibodies directed towards the human or animal interleukin-2 receptor
IT9006602A0 (it) Test immunoenzimatico per la ricerca e determinazione degli anticorpi anti-ss-dna.
DE59106983D1 (de) Vorrichtung zur Kompensation thermischer Dehnungen.
NO912192D0 (no) Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
ITFR910004A1 (it) Sistema di collaudo finale di di cinescopi.
FR2657184B1 (fr) Chevalet pour la presentation de documents.
IT221494Z2 (it) Connettore perfezionato per televisore o simili
FI956041A (fi) Kompositiot ja diagnostiset menetelmät, joissa käytetään monoklonaalisia vasta-aineita CD44V6 vastaan
NO890820D0 (no) Utskytningsrampe for fyrverkerigjenstander.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition